1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Biomarcadores y dianas terapéuticas

Biomarcadores y dianas terapéuticas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Nogales A, Sicilia MÁ, de la Pinta C, García-Barriocanal E, García-Tejedor ÁJ, Guadalupe D.

    Evaluating the detection of small brain lesions in magnetic resonance using deep learning.

    Frontiers in Neuroscience . 20: 1833713-1833713.

    [doi:10.3389/fnins.2026.1833713]

  • Pérez-Ruiz A, Ruiz-Cañas L, Batres S, Ferreras-Martín R, Pinto-Díez C, Yagüe B, Pérez-Morgado MI, Sacristán S, Ruz-Caracuel I, Páez SC, Sanchez-Perez I, González VM, Alcalá S, Martín ME, Sainz B Jr.

    Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cells.

    JOURNAL OF BIOMEDICAL SCIENCE . 33(1): .

    [doi:10.1186/s12929-026-01275-6]

  • Rubio I, Candela A, Echarri G, Callejas R, Tamayo E, Nagore D, Núñez-Córdoba JM, Vives M.

    Preoperative angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and acute kidney injury after high-risk cardiac surgery: a multicenter prospective cohort study.

    Brazilian Journal of Anesthesiology . 76(4): 844786-844786.

    [doi:10.1016/j.bjane.2026.844786]

  • de la Pinta C, Gamero V, Muriel A, Capuz AB, Moris R, MARTÍN, M., Alarza M, Montero A, Muñoz MT, Hernanz R, García Bermejo ML, Sancho S.

    Phase I study of stereotactic ablative radiotherapy (SABR) in inoperable breast cancer.

    BREAST . 87: 104787-104787.

    [doi:10.1016/j.breast.2026.104787]

  • de la Pinta C, Medina AA.

    Artificial Intelligence and Urology in Spain: From Technological Promise to Real Clinical Practice.

    ARCHIVOS ESPANOLES DE UROLOGIA . 79(5): 710-718.

    [doi:10.56434/j.arch.esp.urol.20267905.84]

  • Abal-Sanisidro M, Ruiz-Cañas L, Batres-Ramos S, Blanco MG, García-Bermejo ML, García-Fernández J, Rodríguez-Cobo L, López-Higuera JM, Sainz B Jr, de la Fuente M.

    Evaluation of Self-Illuminating Nanoconjugates Against Pancreatic Ductal Adenocarcinoma.

    International Journal of Nanomedicine . 21: 545161-545161.

    [doi:10.2147/IJN.S545161]

  • Piredda R, Rodríguez Martínez LG, Martinez-Ortega J, López Ferraz A, Villatoro-Gómez S, Martín-García E, García-Bermejo ML, Almendral JM, Stamatakis K, Revilla Y.

    Effects of Multifrequency Electromagnetic Pulses on tumor growth in immunocompetent mice.

    Scientific Reports . 16(1): .

    [doi:10.1038/s41598-026-49151-5]

  • Franzese C, Tanadini-Lang S, Verellen D, Wiersema L, Hörner-Rieber J, Romero AM, Pasquier D, Bruynzeel A, Boda-Heggemann J, Depuydt T, Sibolt P, Douir N, Kuncman L, Beijst C, Stephens H, de la Pinta C, Cuccia F, Milder M, Nicosia L, Onishi H, Louie AV, Sahgal A, Lo SS, Slotman BJ, Guckenberger M, Scorsetti M.

    Clinical practice, barriers to implementation, and priorities for equitable access of Stereotactic Body Radiation Therapy: An analysis of the global status by the ESTRO SBRT Focus Group.

    Clinical and Translational Radiation Oncology . 57: 101096-101096. Nº de citas: 3

    [doi:10.1016/j.ctro.2025.101096]

  • Rodríguez-Serrano M, Martín-García E, Alonso-Andrés P, Conde-Moreno E, Pian H, Del Moral-Salmoral J, Alcharani N, Menacho-Román M, Crespo-Toro L, Ramos-Muñoz ME, Zaragoza C, Rincón LM, Barderas MG, García-Bermejo ML.

    Dynamic microRNA Signatures as Biomarkers for Cardiac Ischemia and Remodeling.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 27(3): . Nº de citas: 1

    [doi:10.3390/ijms27031488]

  • Castillo M, Casado-Gómez-Pallete J, Lázaro-Bailón J, Iniesta-Chamorro JM, García-Bermejo ML, Sancho S, Hernando ME, de la Pinta C.

    Validation of a patient-based strategy for ambulatory monitoring of oncological pain by a mobile application.

    Scientific Reports . 16(1): 5404-5404. Nº de citas: 2

    [doi:10.1038/s41598-025-34057-5]

  • Pistollato F, Furtmann F, Straccia M, Avey M, Azilagbetor DM, Camp C, Delaney C, Ferreira GS, Garcia-Bermejo ML, Gastaldello A, Gurusamy K, Holden L, Kimmelman J, Lohse S, Marigliani B, Menon JML, Ritskes-Hoitinga M, Sarasija S, Tagle D, Tripodi IJ, Turner J, Wehling M, Costantino H.

    Evaluating the translational value of preclinical models: Available tools and frameworks, challenges and strategies.

    ATLA-ALTERNATIVES TO LABORATORY ANIMALS . 54(1): 10-27. Nº de citas: 1

    [doi:10.1177/02611929251398821]

  • de la Pinta C, Domínguez A, Gallego Gasqué VM, Castillo ME, Fernández Martín P, Helguera A, Gómez Blasco P, de Los Santos G.

    Survey to evaluate the usefulness of a clinical ethics committee service and analyze the most frequent ethical conflicts in clinical ethics consulting at the Ramon y Cajal University Hospital.

    Revista clinica espanola . 225(10): 502390-502390.

    [doi:10.1016/j.rceng.2025.502390]

  • Kuncman L, la Pinta C, Milder MTW, Romero AM, Guckenberger M, Franzese C, Scorsetti M, Bruc B, Verellen D, Tanadini-Lang S.

    Definition and requirements for stereotactic radiotherapy: a systematic review

    RADIOTHERAPY AND ONCOLOGY . 211: 111107-111107. Nº de citas: 15

    [doi:10.1016/j.radonc.2025.111107]

  • Audisio A, Gallio C, Velenik V, Meillat H, Ruiz-Garcia E, Riesco MC, Alecha JS, Rasschaert G, Carvalho C, Randrian V, Kirac I, Hernando J, Artaç M, O'Connor JM, Waldhorn I, Braam PM, Shamseddine A, Moretto R, de la Pinta C, De Felice F, Dulskas A, Páez López-Bravo D, Vanden Bulcke A, Bock F, Deleporte A, Van Den Eynde M, Geboes KP, Loi M, Messina M, Houlzé-Laroye C, Puccini A, Pastorino A, Papamichael D, Fiore M, Sur D, Eid M, Antoun C, Salati M, Garajovà I, Jakubauskas M, Tomášek J, Sousa Pinto CM, Schwingel J, Morano F, Adams RA, Dermine A, Chau A, Javed MA, Ghidini M, Fiorica F, Montenegro P, Petrillo A, Spolverato G, Mulet Margalef N, Diaz M, Baratelli C, Puleo F, Karampeazis A, Sert F, Gilliaux Q, De Stefano A, Liberale G, Moretti L, Martinive P, Deltuvaite Thomas V, Staggs V, Saad ED, Van Laethem JL, Sclafani F.

    Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    JAMA Oncology . 11(9): 1045-1054. Nº de citas: 20

    [doi:10.1001/jamaoncol.2025.2026]

  • Xenophontos E, Giaj Levra N, Durieux V, van Geffen WH, Grisay G, De La Pinta Alonso C, Arasanz H, Prisciandaro E, Ferrara R, Derks J, Von der Thusen J, Dickhoff C, Brandão M, Faivre-Finn C, Edwards J, Ruysscher D, Remon J, Dingemans AC, Berghmans T.

    Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group

    LUNG CANCER . 207: 108671-108671. Nº de citas: 9

    [doi:10.1016/j.lungcan.2025.108671]

  • Paniagua-Iglesias P, Rincón-Ferrari MD, Candela-Toha A, Marcos-Jubilar M, Barquero-Lopez M, Gich-Saladich I, Medina-Marrero L, Bosch-Llobet A, Garrido-Fleischmann D, Ordoñez-Llanos J, Urrutia-Cuchí G.

    Improving the Compliance of Massive Hemorrhage Protocols Through Education Is Associated with Patient Survival

    Journal of Clinical Medicine . 14(13): .

    [doi:10.3390/jcm14134632]

  • Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, Garcia-Osuna R, Linares T, Díaz M, Martín N, Barros X, Marco H, Navarro MI, Esparza N, Elias S, Coloma A, Roberto Robles N, Agraz I, Poch E, Rodas L, Lozano V, Fernández-Fernández B, Hernández E, Martínez MI, Stanescu RI, Moirón JP, García-Fernández N, Goicoechea M, Calero F, Bonet J, Liaño F, Pascual J, Praga M, Fulladosa X, Soler MJ.

    A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study.

    Nefrologia . 45(5): 360-368. Nº de citas: 4

    [doi:10.1016/j.nefroe.2025.04.004]

  • Bara-Ledesma N, Viteri-Noel A, Lopez Rodriguez M, Stamatakis K, Fabregate M, Vazquez-Santos A, Gomez Del Olmo V.

    Advances in Gene Therapy for Rare Diseases: Targeting Functional Haploinsufficiency Through AAV and mRNA Approaches

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(2): . Nº de citas: 16

    [doi:10.3390/ijms26020578]